Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
US Army
Argus Health
Cipla
Cantor Fitzgerald
Federal Trade Commission
Julphar
Harvard Business School
UBS

Generated: January 22, 2018

DrugPatentWatch Database Preview

CLINDAMYCIN PHOSPHATE Drug Profile

« Back to Dashboard

Which patents cover Clindamycin Phosphate, and when can generic versions of Clindamycin Phosphate launch?

Clindamycin Phosphate is a drug marketed by Perrigo Uk Finco, Fougera Pharms, Abraxis Pharm, Alvogen Inc, Bedford, Bristol Myers Squibb, Fresenius Kabi Usa, Igi Labs Inc, Loch, Marsam Pharms Llc, Mylan Labs Ltd, Sagent Pharms, Solopak, Teva Parenteral, Watson Labs, West-ward Pharms Int, Boca Pharma Llc, Fougera Pharms Inc, G And W Labs Inc, Novast Labs Ltd, Perrigo New York, Taro Pharm Inds, Teligent Pharma Inc, Vintage Pharms, Wockhardt, Akorn, Actavis Labs Ut Inc, Mylan Pharms Inc, Perrigo Israel, Tolmar, Actavis Mid Atlantic, Baxter Hlthcare Corp, Akorn Inc, Sandoz Inc, Abbvie, and Baxter Hlthcare. and is included in fifty-eight NDAs.

The generic ingredient in CLINDAMYCIN PHOSPHATE is clindamycin phosphate; tretinoin. There are fifty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Drug patent expirations by year for CLINDAMYCIN PHOSPHATE
Pharmacology for CLINDAMYCIN PHOSPHATE

US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt CLINDAMYCIN PHOSPHATE clindamycin phosphate SOLUTION;TOPICAL 063304-001 Jul 15, 1997 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms CLINDAMYCIN PHOSPHATE clindamycin phosphate SOLUTION;TOPICAL 065254-001 Feb 14, 2006 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Tolmar CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 203688-001 Aug 25, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 201692-001 May 31, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE benzoyl peroxide; clindamycin phosphate GEL;TOPICAL 065443-001 Aug 11, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic CLINDAMYCIN PHOSPHATE AND TRETINOIN clindamycin phosphate; tretinoin GEL;TOPICAL 202564-001 Jun 12, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn Inc CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 203048-002 Apr 4, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER clindamycin phosphate INJECTABLE;INJECTION 201692-002 May 31, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 063068-001 Aug 28, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms Inc CLINDAMYCIN PHOSPHATE clindamycin phosphate SOLUTION;TOPICAL 064159-001 Jun 5, 1997 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Julphar
Federal Trade Commission
Medtronic
McKesson
Cerilliant
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot